Immune atlas at cell level points to new combination treatment for incurable childhood cancer
A detailed 'atlas' of neuroblastoma tumors points to a new target for immunotherapy. Scientists from the Princess Máxima Center for...
Jan 8, 2024
How research helped lead to FDA approval of a pediatric neuroblastoma drug
The drug, called eflornithine (DFMO) and newly branded as IWILFIN by US WorldMeds, reduces the risk of relapse for pediatric high-risk...
Dec 20, 2023
Team develops gene therapy to ‘pre-treat’ neuroblastoma tumors
University of Texas at Dallas researchers have developed a potential gene therapy to “pre-treat” neuroblastoma tumors in order to make...
Dec 13, 2023
NIH researchers develop approach that could help supercharge T-cell therapies against solid tumors
Researchers at the National Institutes of Health have developed a way to potentially increase the effectiveness of T cell–based...
Nov 3, 2023
Developing ‘kinder’ treatments for a devastating childhood cancer
Neuroblastomas can be devastating to children and their families and the treatments can be harsh. But thanks to scientists, some...
Sep 20, 2023
Researchers discover new therapeutic approach for neuroblastoma
A team of researchers at University Medicine Halle has discovered the processes involved in the development of neuroblastomas. The...
Aug 31, 2023
'New' immune system responds better to therapy
Scientists at St. Anna Children's Cancer Research Institute and the Eberhard Karls University of Tübingen have shown that immunotherapy ...
Aug 15, 2023
Childhood cancer: Vulnerability in the immune response against metastases discovered
Scientists led by Sabine Taschner-Mandl, Ph.D., St. Anna Children's Cancer Research Institute, and Nikolaus Fortelny, Ph.D., Paris Lodron...
Jun 27, 2023
CHOP doctor making strides in finding cure for "holy grail of childhood cancers"
Mossé is working on groundbreaking science at the Children's Hospital of Philadelphia. The once undruggable neuroblastoma -- a rare...
Jun 26, 2023
Late-toxicity burden high among survivors of high-risk neuroblastoma
Survivors of high-risk neuroblastoma face a substantial burden of late toxicity, according to study results presented at ASCO Annual...
Jun 6, 2023